Insmed (INSM) director sells 5,000 shares at $204.58
Insmed Inc. (INSM) reported an insider transaction on a Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insmed Inc. (INSM) reported an insider transaction on a Form 4 filing. A company director sold 5,000 shares of Insmed common stock on November 24, 2025, identified with transaction code "S" for a sale. The shares were sold at a price of $204.58 per share in an open market transaction.
After this sale, the director beneficially owns 58,729 shares of Insmed common stock, held directly. The filing reflects a routine update to the director’s ownership position and does not report any derivative securities activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $204.58 | $1.02M |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Insmed (INSM) report on this Form 4?
What is the reporting person’s relationship to Insmed (INSM)?
Does this Insmed (INSM) Form 4 include any derivative securities transactions?
What transaction code is shown for the Insmed (INSM) insider trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.